Bioventus Inc. (BVS) stock

BVSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Nov 2, 2026Score 14/3033% below fair value

$10.86−0.13 (-1.18%)

Close on Nov 12, 2026Market cap $913.24MP/E 13.6Yield –

Bioventus profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Bioventus's profit margin for the twelve months ending Sep 26, 2026 was 9.8%. For fiscal 2025 it was 4.0%, against -6.3% the year before. The highest annual figure on record is 5.1% in fiscal 2020.

Annual profit margin

Period	Period end	Value	Change (pts)
FY2025	Dec 31, 2025	4.0%	+10.3
FY2024	Dec 31, 2024	-6.3%	+24.2
FY2023	Dec 31, 2023	-30.5%	+0.5
FY2022	Dec 31, 2022	-31.0%	−35.5
FY2021	Dec 31, 2021	4.5%	−0.6
FY2020	Dec 31, 2020	5.1%	+3.1
FY2019	Dec 31, 2019	2.0%	–

Quarterly profit margin

Change is against the same quarter a year earlier.

Period	Period end	Value	Change (pts)
Q3 FY2026	Sep 26, 2026	4.2%	+1.9
Q2 FY2026	Jun 27, 2026	21.8%	+16.8
Q1 FY2026	Mar 28, 2026	2.4%	+4.5
Q4 FY2025	Dec 31, 2025	9.3%	+9.6
Q3 FY2025	Sep 27, 2025	2.3%	+6.0
Q2 FY2025	Jun 28, 2025	5.1%	+22.0
Q1 FY2025	Mar 29, 2025	-2.1%	+1.6
Q4 FY2024	Dec 31, 2024	-0.3%	+4.2
Q3 FY2024	Sep 28, 2024	-3.7%	+2.3
Q2 FY2024	Jun 29, 2024	-17.0%	−14.3
Q1 FY2024	Mar 30, 2024	-3.8%	+113.1
Q4 FY2023	Dec 31, 2023	-4.5%	+20.9
Q3 FY2023	Sep 30, 2023	-6.0%	+78.1
Q2 FY2023	Jul 1, 2023	-2.7%	+2.5
Q1 FY2023	Apr 1, 2023	-116.9%	−107.3
Q4 FY2022	Dec 31, 2022	-25.4%	−25.1
Q3 FY2022	Oct 1, 2022	-84.1%	−83.1
Q2 FY2022	Jul 2, 2022	-5.2%	−1.4
Q1 FY2022	Apr 2, 2022	-9.6%	−40.1
Q4 FY2021	Dec 31, 2021	-0.3%	−3.1
Q3 FY2021	Oct 2, 2021	-1.0%	−10.8
Q2 FY2021	Jul 3, 2021	-3.8%	+6.2
Q1 FY2021	Apr 3, 2021	30.5%	+16.6
Q4 FY2020	Dec 31, 2020	2.8%	–
Q3 FY2020	Sep 26, 2020	9.8%	–
Q2 FY2020	Jun 27, 2020	-9.9%	–
Q1 FY2020	Mar 28, 2020	13.9%	–